Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

News · April 05, 2022

AAD 2022: Dupilumab Improves Itch, Skin Lesions in Prurigo Nodularis

At 24 weeks, significantly more patients randomly assigned to dupilumab achieved 4-point reduction in WI-NRS

PracticeUpdate Editorial Team


Further Reading